HEALTH

Innovating health, empowering lives — from biotech breakthroughs to accessible care for all

Health and biotech investment is a core pillar within KICL’s mission and the ODT Funding Program, enabling capital to directly support life-saving services, resilient health infrastructure, and biomedical innovation. By integrating investments across biotech R&D, medicine manufacturing, emergency response, and disease control, KICL positions healthcare not only as a development objective, but as a foundation for social equity and economic stability. These investments are particularly impactful in underserved regions—like the Horn of Africa—where KICL’s health platform empowers communities, strengthens institutions, and aligns medical advancement with long-term impact, sustainability, and Shariah-compliant values.

Kingdom Medical Health and Wellness Limited

Kingdom Medical Health and Wellness Limited is the healthcare and biotech subsidiary of Kingdom Investment Corporation Limited (KICL), dedicated to transforming global health through strategic investment, innovation, and accessibility. With operations spanning biotech R&D, pharmaceutical production, hospital and clinic development, emergency services, and infectious disease response, the company offers a fully integrated approach to healthcare investment. From state-of-the-art medical infrastructure to life-saving public health interventions in Africa and the Global South, Kingdom Health bridges high-end technology with inclusive care. Grounded in sustainability and ethical finance, the company ensures that every investment advances both clinical outcomes and community well-being.

At Kingdom Medical Health and Wellness Limited, we are dedicated to advancing the field of healthcare through strategic investments in biotechnology, vaccine development, and medical science intellectual property research and development (R&D). We recognize the transformative potential of breakthrough discoveries in these areas and actively invest in cutting-edge R&D projects. By fostering innovation and supporting the development of novel treatments and therapies, we aim to improve patient outcomes and address unmet medical needs on a global scale.

Our commitment to making healthcare accessible and affordable drives our investment in medicine production and distribution. We understand the importance of providing high-quality, cost-effective medications to both high-end markets and underserved populations. Through strategic partnerships with pharmaceutical manufacturers, we ensure the efficient production and distribution of a wide range of medicines. By leveraging economies of scale and employing robust supply chain management practices, we strive to improve access to essential medications and contribute to the overall well-being of individuals worldwide.

Kingdom Medical Health and Wellness Limited recognizes the vital role that healthcare infrastructure plays in delivering quality medical services. As part of our comprehensive investment approach, we actively invest in the construction, management, and operation of medical treatment facilities, including hospitals, clinics, and medical centres. Our goal is to create state-of-the-art healthcare environments that prioritize patients’ comfort, safety, and efficient healthcare delivery. By collaborating with industry experts and leveraging cutting-edge technologies, we ensure that our facilities meet the highest standards of medical care.

Addressing the urgent healthcare needs of developing regions is a core focus for Kingdom Medical Health and Wellness Limited. We are committed to providing emergency medical services and medications to the underserved communities. By establishing partnerships with local healthcare organizations and leveraging our expertise in supply chain management, we strive to ensure the timely delivery of life-saving medications and emergency medical support. Our aim is to bridge the gap in healthcare access in developing regions in order to save lives and improve the overall health and well-being of the communities that face significant challenges in accessing quality healthcare services.

Kingdom Medical Health and Wellness Limited also places a strong emphasis on addressing pandemic diseases in developing regions, particularly in Africa. We recognize the urgent need to combat prevalent diseases such as HIV/AIDS, malaria, tuberculosis, and other infectious diseases that disproportionately affect these regions. Through targeted investments in research, treatment development, and healthcare infrastructure, we strive to improve the diagnosis, treatment, and prevention of these diseases. By collaborating with local healthcare providers, international organizations, and governments, we aim to implement comprehensive healthcare programs that effectively address the specific challenges associated with pandemic diseases, ultimately reducing their impact and improving the health outcomes of the affected communities.

Key Capacities

Biotech
Innovation

Invests in R&D, and commercialization of next-gen pharmaceuticals, diagnostics, and biomedical technologies.

Healthcare Infrastructure

Develops hospitals, mobile clinics, and emergency care systems to serve both urban and underserved regions.

Disease
Response

Implements epidemic control programs and rapid response systems for emerging infectious diseases and public health crises.

Medical
Supply

Manages the procurement and distribution of essential medicines, devices, and wellness products through global supply chains.

Equity
Access

Promotes universal health access through inclusive care models, public-private partnerships, and culturally tailored service delivery.

HEALTH

Innovating health, empowering lives — from biotech breakthroughs to accessible care for all

Kingdom Medical Health and Wellness Limited

Key Capacities

Biotech Innovation

Healthcare Infrastructure

Disease Response

Medical Supply

Equity Access

Biotech
Innovation

Disease
Response

Medical
Supply

Equity
Access